In another study of 32 MDS patients who were either resistant or sensitized to 5-AZA-dC, DCK and CDA gene expression levels were comparable, but the ratio of CDA to DCK was significantly higher in non-responders than in responders, suggesting that this could be a mechanism of primary resistance (84). This evidence concerns the gene DCK and myelodysplastic syndrome.